- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 40 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
MC3.2: 3 residues within 4Å:- Chain A: W.24, Y.33
- Ligands: MC3.3
Ligand excluded by PLIPMC3.3: 7 residues within 4Å:- Chain A: L.22, C.23, W.24, R.25, Y.29, Y.33
- Ligands: MC3.2
Ligand excluded by PLIPMC3.4: 5 residues within 4Å:- Chain A: L.54, Q.58, M.61, F.62, V.253
Ligand excluded by PLIPMC3.5: 4 residues within 4Å:- Chain A: I.38
- Chain C: L.14
- Ligands: MC3.19, MC3.27
Ligand excluded by PLIPMC3.6: 6 residues within 4Å:- Chain A: L.40, Y.44, R.47, V.272, V.273, F.278
Ligand excluded by PLIPMC3.7: 2 residues within 4Å:- Chain A: V.272, V.273
Ligand excluded by PLIPMC3.8: 7 residues within 4Å:- Chain A: R.13, L.14
- Chain E: Y.33, G.34, L.37, I.38
- Ligands: MC3.42
Ligand excluded by PLIPMC3.9: 13 residues within 4Å:- Chain A: L.14, G.15, S.18, R.19, L.21, L.22
- Chain E: I.38, F.39, Y.245, S.246, L.249, L.252
- Ligands: MC3.42
Ligand excluded by PLIPMC3.11: 3 residues within 4Å:- Chain B: W.24, Y.33
- Ligands: MC3.12
Ligand excluded by PLIPMC3.12: 7 residues within 4Å:- Chain B: L.22, C.23, W.24, R.25, Y.29, Y.33
- Ligands: MC3.11
Ligand excluded by PLIPMC3.13: 5 residues within 4Å:- Chain B: L.54, Q.58, M.61, F.62, V.253
Ligand excluded by PLIPMC3.14: 4 residues within 4Å:- Chain B: I.38
- Chain D: L.14
- Ligands: MC3.28, MC3.36
Ligand excluded by PLIPMC3.15: 6 residues within 4Å:- Chain B: L.40, Y.44, R.47, V.272, V.273, F.278
Ligand excluded by PLIPMC3.16: 2 residues within 4Å:- Chain B: V.272, V.273
Ligand excluded by PLIPMC3.17: 7 residues within 4Å:- Chain B: R.13, L.14
- Chain C: Y.33, G.34, L.37, I.38
- Ligands: MC3.24
Ligand excluded by PLIPMC3.18: 13 residues within 4Å:- Chain B: L.14, G.15, S.18, R.19, L.21, L.22
- Chain C: I.38, F.39, Y.245, S.246, L.249, L.252
- Ligands: MC3.24
Ligand excluded by PLIPMC3.19: 13 residues within 4Å:- Chain A: I.38, F.39, Y.245, S.246, L.249, L.252
- Chain C: L.14, G.15, S.18, R.19, L.21, L.22
- Ligands: MC3.5
Ligand excluded by PLIPMC3.21: 3 residues within 4Å:- Chain C: W.24, Y.33
- Ligands: MC3.22
Ligand excluded by PLIPMC3.22: 7 residues within 4Å:- Chain C: L.22, C.23, W.24, R.25, Y.29, Y.33
- Ligands: MC3.21
Ligand excluded by PLIPMC3.23: 5 residues within 4Å:- Chain C: L.54, Q.58, M.61, F.62, V.253
Ligand excluded by PLIPMC3.24: 4 residues within 4Å:- Chain B: L.14
- Chain C: I.38
- Ligands: MC3.17, MC3.18
Ligand excluded by PLIPMC3.25: 6 residues within 4Å:- Chain C: L.40, Y.44, R.47, V.272, V.273, F.278
Ligand excluded by PLIPMC3.26: 2 residues within 4Å:- Chain C: V.272, V.273
Ligand excluded by PLIPMC3.27: 7 residues within 4Å:- Chain A: Y.33, G.34, L.37, I.38
- Chain C: R.13, L.14
- Ligands: MC3.5
Ligand excluded by PLIPMC3.28: 13 residues within 4Å:- Chain B: I.38, F.39, Y.245, S.246, L.249, L.252
- Chain D: L.14, G.15, S.18, R.19, L.21, L.22
- Ligands: MC3.14
Ligand excluded by PLIPMC3.30: 3 residues within 4Å:- Chain D: W.24, Y.33
- Ligands: MC3.31
Ligand excluded by PLIPMC3.31: 7 residues within 4Å:- Chain D: L.22, C.23, W.24, R.25, Y.29, Y.33
- Ligands: MC3.30
Ligand excluded by PLIPMC3.32: 5 residues within 4Å:- Chain D: L.54, Q.58, M.61, F.62, V.253
Ligand excluded by PLIPMC3.33: 4 residues within 4Å:- Chain D: I.38
- Chain E: L.14
- Ligands: MC3.37, MC3.45
Ligand excluded by PLIPMC3.34: 6 residues within 4Å:- Chain D: L.40, Y.44, R.47, V.272, V.273, F.278
Ligand excluded by PLIPMC3.35: 2 residues within 4Å:- Chain D: V.272, V.273
Ligand excluded by PLIPMC3.36: 7 residues within 4Å:- Chain B: Y.33, G.34, L.37, I.38
- Chain D: R.13, L.14
- Ligands: MC3.14
Ligand excluded by PLIPMC3.37: 13 residues within 4Å:- Chain D: I.38, F.39, Y.245, S.246, L.249, L.252
- Chain E: L.14, G.15, S.18, R.19, L.21, L.22
- Ligands: MC3.33
Ligand excluded by PLIPMC3.39: 3 residues within 4Å:- Chain E: W.24, Y.33
- Ligands: MC3.40
Ligand excluded by PLIPMC3.40: 7 residues within 4Å:- Chain E: L.22, C.23, W.24, R.25, Y.29, Y.33
- Ligands: MC3.39
Ligand excluded by PLIPMC3.41: 5 residues within 4Å:- Chain E: L.54, Q.58, M.61, F.62, V.253
Ligand excluded by PLIPMC3.42: 4 residues within 4Å:- Chain A: L.14
- Chain E: I.38
- Ligands: MC3.8, MC3.9
Ligand excluded by PLIPMC3.43: 6 residues within 4Å:- Chain E: L.40, Y.44, R.47, V.272, V.273, F.278
Ligand excluded by PLIPMC3.44: 2 residues within 4Å:- Chain E: V.272, V.273
Ligand excluded by PLIPMC3.45: 7 residues within 4Å:- Chain D: Y.33, G.34, L.37, I.38
- Chain E: R.13, L.14
- Ligands: MC3.33
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 40 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-1: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
DE
E - Membrane
-
We predict this structure to be a membrane protein.